Clinical Trial Update: Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing dual hypothermic oxygenated perfusion of DCD liver grafts to prevent biliary complications after transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Failure

Snippet

Sponsor: Robert J. Porte | Conditions: Liver Failure, End Stage Liver Disease | Phase 3 | Status: COMPLETED